Press release
January 8, 2025
Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer
Odyssey Therapeutics, Inc. (ODTX)
BOSTON, January 8, 2025 — Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed